{"ticker": {"uuid": "26a8013b-0455-4139-96dc-be5b6ba8683d", "symbol": "002550", "name": "Changzhou Qianhong Biopharma CO.,LTD", "exchange": "SHZ", "country": "CN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Enterprise value to EBIT forward of Changzhou Qianhong Bio-Pharma Co., Ltd. Class A \u2013 SZSE:002550", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPM29CVU5uajFNY0VQNk9wbzFIMVVDTlo1bTBEQWJKbW1jdmpRbWNZWDZ6WktzNWhnZ3ByamVybTZlTnV6VXlxNVZiLXdpMVhwVzZ5ckphaVRIYUxvWHJ0MDBDdXFXc0pGQ0w5ekRXQXh0aWYwX1I1NkJaVmVDeDhwLUtuVTZPdDFOUlh2N1pkQW9BT0JPYTRLNXc1UXBKV1NzSWxBZ2czVW81UjA?oc=5", "source_name": "TradingView", "published_at": "2026-07-12T11:55:39+00:00", "published_display": "12 Jul 2026 11:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Changzhou Qianhong Bio-Pharma Co., Ltd. Class A \u2013 SZSE:002550", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQR3lXTlBPTHJMc2VrUWdqbnZlS3VnMlVNUTJEQ3hZeEdvY1lQSmtLc184T2RRWjFBd3VuMjZ5UTU5NGJIRG9LOWlUcVRlZHc5ejNnZ2JpMlZ3cmpmRUxjVk1GRWNBb09VS29DSThfeTlvalBMMlh1SzQweTNUaUtrTUtrZUxvbF8xSmI0UGRfS2VIVlo5N3R2OTRjRXZJdw?oc=5", "source_name": "TradingView", "published_at": "2026-07-12T05:38:30+00:00", "published_display": "12 Jul 2026 05:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chinese drugmaker Changzhou Qianhong Bio-pharma starts construction of RMB 1 billion facility to expand production of polysaccharides and enzymes drugs", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwJBVV95cUxNWWxYMGgxZkxCa0YwMmR0UGZOSlh3NEZfdGF0QjBWNUdFX0dlck1VTWNkWWFVNmdWY04zcHVUQXNHUTBCZjFPM3ZURXdBYzVfVThSa1FKNmxvX1J1dDA0aUxNS1hqajB5Nk9KZEtvSmpGWXhjbjExQlE5ci11ckJ0U3lNRk01Zkt1bWZiZW9jZTEzOGVQeXFfbUswcXZDa1JqcXV6dVBscG1OSGhMQmNxeXNSbVlxeFhCOTJ3OTFRVHJKWHNjRGpTMzg5SUEzenN5WExTQWpUUzRnUm1qcFA3cXFZMHJRUEhkVDk3R09lcGxoZU9yOHRCcnFDOFdTQ0FUZThKRkw0dw?oc=5", "source_name": "BioSpace", "published_at": "2018-12-04T08:00:00+00:00", "published_display": "04 Dec 2018 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Enterprise value to EBIT forward of Changzhou Qianhong Bio-Pharma Co., Ltd. Class A \u2013 SZSE:002550", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPM29CVU5uajFNY0VQNk9wbzFIMVVDTlo1bTBEQWJKbW1jdmpRbWNZWDZ6WktzNWhnZ3ByamVybTZlTnV6VXlxNVZiLXdpMVhwVzZ5ckphaVRIYUxvWHJ0MDBDdXFXc0pGQ0w5ekRXQXh0aWYwX1I1NkJaVmVDeDhwLUtuVTZPdDFOUlh2N1pkQW9BT0JPYTRLNXc1UXBKV1NzSWxBZ2czVW81UjA?oc=5", "source_name": "TradingView", "published_at": "2026-07-12T11:55:39+00:00", "published_display": "12 Jul 2026 11:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Changzhou Qianhong Bio-Pharma Co., Ltd. Class A \u2013 SZSE:002550", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQR3lXTlBPTHJMc2VrUWdqbnZlS3VnMlVNUTJEQ3hZeEdvY1lQSmtLc184T2RRWjFBd3VuMjZ5UTU5NGJIRG9LOWlUcVRlZHc5ejNnZ2JpMlZ3cmpmRUxjVk1GRWNBb09VS29DSThfeTlvalBMMlh1SzQweTNUaUtrTUtrZUxvbF8xSmI0UGRfS2VIVlo5N3R2OTRjRXZJdw?oc=5", "source_name": "TradingView", "published_at": "2026-07-12T05:38:30+00:00", "published_display": "12 Jul 2026 05:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chinese drugmaker Changzhou Qianhong Bio-pharma starts construction of RMB 1 billion facility to expand production of polysaccharides and enzymes drugs", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwJBVV95cUxNWWxYMGgxZkxCa0YwMmR0UGZOSlh3NEZfdGF0QjBWNUdFX0dlck1VTWNkWWFVNmdWY04zcHVUQXNHUTBCZjFPM3ZURXdBYzVfVThSa1FKNmxvX1J1dDA0aUxNS1hqajB5Nk9KZEtvSmpGWXhjbjExQlE5ci11ckJ0U3lNRk01Zkt1bWZiZW9jZTEzOGVQeXFfbUswcXZDa1JqcXV6dVBscG1OSGhMQmNxeXNSbVlxeFhCOTJ3OTFRVHJKWHNjRGpTMzg5SUEzenN5WExTQWpUUzRnUm1qcFA3cXFZMHJRUEhkVDk3R09lcGxoZU9yOHRCcnFDOFdTQ0FUZThKRkw0dw?oc=5", "source_name": "BioSpace", "published_at": "2018-12-04T08:00:00+00:00", "published_display": "04 Dec 2018 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 39, "total_relevant": 3, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 3, "score": 50, "total": 3, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 1.65, "count": 3}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 6.65, "latest_week": "2026-07-17", "one_week_move": -3.2, "four_week_move": 13.7, "twelve_week_move": -6.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.082942, "market_dynamics_buy_signal": false, "relative_strength": -19.593048, "fair_value_gap": 4.2, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 50.7495, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.2% over one week, +13.7% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 57, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 2}, {"label": "BioSpace", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 3}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "3", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-3.2% over one week, +13.7% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Enterprise value to EBIT forward of Changzhou Qianhong Bio-Pharma Co., Ltd. Class A \u2013 SZSE:002550"}], "updated_at": "2026-07-24T15:40:27.042698+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}